About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

25

Oct

2016

Prime Therapeutics: Florida Blue - Processing Update for Generic Benicar® or Benicar HCT®

Effective October 26th 2016

Dear Valued Provider,

On October 26th, 2016, generic Benicar and Benicar HCT (olmesartan and olmesartan/ HCTZ) will become available to the market. Olmesartan and olmesartan/HCTZ will require a Prior Authorization by Florida Blue until multiple manufacturers become available or the price decreases. The innovator product Benicar/HCT will continue to be covered*.

Action Required

If Participating Pharmacies receive a prescription for olmesartan or olmesartan/HCTZ, they will need to submit brand name Benicar/HCT in order to receive a paid claim. If a prescription for olmesartan or olmesartan/HCTZ is submitted instead of brand name Benicar/HCT, the claim will reject at point-of-sale (POS) with the following reject message:

  • NCPDP Reject Code 75: Prior Authorization
  • Secondary Message: "Brand Benicar/HCT preferred, generic requires PA"

For questions regarding coverage of Benicar/HCT or the new product, please refer Covered Persons to the Customer Service number on the back of their Florida Blue ID card.

If you have any questions regarding claims processing, please call the Prime Contact Center at 800.821.4795.

Sincerely,

Pharmacy Network Management

Prime Therapeutics LLC

* Coverage of Benicar/HCT is dependent on the Covered Person’s benefit plan

25

Oct

2016

CVS Caremark®: REVISED Management of Select Unapproved Products

Effective January 1st 2017

Effective January 1, 2017, CVS Caremark® will exclude coverage for all new-to-market unapproved products and certain existing unapproved products that may be marketed contrary to the Federal Food, Drug, and Cosmetic Act (FFDCA). Coverage will remain for select unapproved products that are legally marketed1 or deemed clinically necessary (e.g., because no alternatives exist).


*Please see attached PDF for the revised communication to reflect the correct Line of Business.

25

Oct

2016

Prime Therapeutics: Blue Cross and Blue Shield of Alabama - Processing Update for Generic Benicar® or Benicar HCT®

Effective October 26th 2016

Dear Valued Provider,

On October 26, 2016, generic Benicar and Benicar HCT (olmesartan and olmesartan/HCTZ) will become available to the market. Olemesartan and olmesartan/HCTZ will not be covered by Blue Cross and Blue Shield of Alabama until multiple manufacturers become available or the price decreases. The innovator products Benicar and Benicar HCT will continue to be covered with a tier 1 copay*.

Action Required

If Participating Pharmacies receive a prescription for olmesartan or olmesartan/HCTZ, they must submit brand name Benicar or Benicar HCT in order to receive a paid claim. If a prescription for olmesartan or olmesartan HCT tablets is submitted instead of brand name Benicar or Benicar HCT, the claim will reject at point-of-sale (POS) with the following reject message:

  • NCPDP Reject Code 70: "Prod/Service Not Covered"
  • Secondary Message: Olmesartan and Olmesartan HCT not covered, use Benicar or Benicar HCT

For questions regarding coverage of Benicar or the new product, please refer Covered Persons to the Customer Service number on the back of their Blue Cross ID card.

If you have any questions regarding claims processing, please call the Prime Contact Center at 800.821.4795.

Sincerely,

Pharmacy Network Management

Prime Therapeutics LLC

* Coverage of Benicar and Benicar HCT is dependent on the Covered Person’s benefit plan

* For State of Alabama Covered Person’s only – brand Benicar and Benicar HCT will continue to process with a tier 4 copay.

* For Auburn University Covered Person’s only – brand Benicar and Benicar HCT will process with a tier 2 copay.

25

Oct

2016

Script Care, Ltd. - Pharmacy Payer Sheet

Effective Septemeber 1st 2016

Please see the attached Payer Sheet for Script Care, Ltd. as the submission of standard NCPDP Telecommunication Standard Guide Version D.0, fields are required by Script Care, LTD Plan Sponsors and must be submitted during processing.

25

Oct

2016

CVS Caremark®: Management of Select Unapproved Products

Effective January 1st 2017

Effective January 1, 2017, CVS Caremark® will exclude coverage for all new-to-market unapproved products and certain existing unapproved products that may be marketed contrary to the Federal Food, Drug, and Cosmetic Act (FFDCA). Coverage will remain for select unapproved products that are legally marketed(1) or deemed clinically necessary (e.g., because no alternatives exist).

*Please see attached PDF for more information.

First 632633634635 Last